Most Minnesotans who took part in the launch year of the state's medical marijuana program reported "substantial benefits" from treatment, including minimal side effects and no serious consequences, the state Health Department said Tuesday.
The study was based on patient surveys and other data.
Smith & Nephew plc (SN) Receives Average Recommendation of "Hold" from Analysts
The Company's funeral services relate to the provision of funerals and ancillary items, such as memorials and floral tributes. Btg has 383,799,000 shares in issue which have a share price of 651.57 giving Btg a market capitalisation of 2.50B GBp.
Asked to rate the benefits of medical cannabis in their treatment on a scale of 1 (no benefit) to 7 (great deal of benefit), 64 percent of patients gave the therapy a 6 or 7. Nine percent indicated little or no benefit. Most patients also reported clinically meaningful reductions in symptoms for conditions including seizures, Tourette syndrome, Crohn's disease and muscle spasms.
Minnesota has among the strictest programs of almost 30 states with medical marijuana laws. The state bans the plant form and restricts marijuana pills and oils to patients with a handful of severe conditions. Due to high costs and an aggressive rollout schedule, the state's two licensed manufacturers lost a combined $11 million in just two years of sales, according to financial documents obtained by The Associated Press.
- Match Previews: Manchester City v West Bromwich Albion
- La La and Carmelo Anthony Spend Mother's Day Together
- Ransomware attacks in 150 countries
- Penguins draw even in series against Senators
- Dwayne Johnson teases cinematic fight with Henry Cavill's Superman
- Trump responds to Clinton with late-night tweets
- Women-only overdose prevention site opens on Vancouver's Downtown Eastside
- Sharapova contrainte à l'abandon — Rome
- Plan unveiled for improvements to NYC's subway system
- The Young Pope sequel The New Pope coming to HBO